SG11201704272YA - Compositions and methods for high efficiency in vivo genome editing - Google Patents

Compositions and methods for high efficiency in vivo genome editing

Info

Publication number
SG11201704272YA
SG11201704272YA SG11201704272YA SG11201704272YA SG11201704272YA SG 11201704272Y A SG11201704272Y A SG 11201704272YA SG 11201704272Y A SG11201704272Y A SG 11201704272YA SG 11201704272Y A SG11201704272Y A SG 11201704272YA SG 11201704272Y A SG11201704272Y A SG 11201704272YA
Authority
SG
Singapore
Prior art keywords
compositions
methods
high efficiency
genome editing
vivo genome
Prior art date
Application number
SG11201704272YA
Inventor
John Verruto
Eric Moellering
Original Assignee
Synthetic Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthetic Genomics Inc filed Critical Synthetic Genomics Inc
Publication of SG11201704272YA publication Critical patent/SG11201704272YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8213—Targeted insertion of genes into the plant genome by homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
SG11201704272YA 2014-12-31 2015-12-31 Compositions and methods for high efficiency in vivo genome editing SG11201704272YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462099014P 2014-12-31 2014-12-31
PCT/US2015/068356 WO2016109840A2 (en) 2014-12-31 2015-12-31 Compositions and methods for high efficiency in vivo genome editing

Publications (1)

Publication Number Publication Date
SG11201704272YA true SG11201704272YA (en) 2017-06-29

Family

ID=56285162

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201906070XA SG10201906070XA (en) 2014-12-31 2015-12-31 Compositions and methods for high efficiency in vivo genome editing
SG11201704272YA SG11201704272YA (en) 2014-12-31 2015-12-31 Compositions and methods for high efficiency in vivo genome editing

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201906070XA SG10201906070XA (en) 2014-12-31 2015-12-31 Compositions and methods for high efficiency in vivo genome editing

Country Status (8)

Country Link
US (2) US11339399B2 (en)
EP (1) EP3240889A4 (en)
JP (2) JP2018500037A (en)
AU (1) AU2015373893B2 (en)
CA (1) CA2972454A1 (en)
IL (1) IL252970B (en)
SG (2) SG10201906070XA (en)
WO (1) WO2016109840A2 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013066438A2 (en) 2011-07-22 2013-05-10 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US11053481B2 (en) 2013-12-12 2021-07-06 President And Fellows Of Harvard College Fusions of Cas9 domains and nucleic acid-editing domains
AU2015298571B2 (en) 2014-07-30 2020-09-03 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
PT3322799T (en) 2015-07-14 2021-06-02 Synthetic Genomics Inc Microorganisms having increased lipid productivity
WO2017023803A1 (en) 2015-07-31 2017-02-09 Regents Of The University Of Minnesota Modified cells and methods of therapy
CA2996599A1 (en) * 2015-09-01 2017-03-09 Dana-Farber Cancer Institute Inc. Systems and methods for selection of grna targeting strands for cas9 localization
JP7109784B2 (en) 2015-10-23 2022-08-01 プレジデント アンド フェローズ オブ ハーバード カレッジ Evolved Cas9 protein for gene editing
US10041079B2 (en) 2015-11-30 2018-08-07 Synthetic Genomics, Inc. Compositions and methods for expressing genes in algae
CA3007635A1 (en) 2015-12-07 2017-06-15 Zymergen Inc. Promoters from corynebacterium glutamicum
US11208649B2 (en) 2015-12-07 2021-12-28 Zymergen Inc. HTP genomic engineering platform
US9988624B2 (en) 2015-12-07 2018-06-05 Zymergen Inc. Microbial strain improvement by a HTP genomic engineering platform
WO2017117425A1 (en) * 2015-12-31 2017-07-06 Synthetic Genomics, Inc. Expression of type i fatty acid synthase genes in eukaryotic algae
WO2018005793A1 (en) 2016-06-30 2018-01-04 Zymergen Inc. Methods for generating a glucose permease library and uses thereof
EP3478833A4 (en) 2016-06-30 2019-10-02 Zymergen, Inc. Methods for generating a bacterial hemoglobin library and uses thereof
US11466269B2 (en) 2016-07-13 2022-10-11 Dsm Ip Assets B.V. CRISPR-Cas system for an algal host cell
CN110214183A (en) 2016-08-03 2019-09-06 哈佛大学的校长及成员们 Adenosine nucleobase editing machine and application thereof
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
JP6829761B2 (en) 2016-09-29 2021-02-10 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Methods for analyzing and optimizing gene editing modules and gene delivery approaches
SG11201903089RA (en) 2016-10-14 2019-05-30 Harvard College Aav delivery of nucleobase editors
JP7181862B2 (en) 2016-10-18 2022-12-01 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Tumor-infiltrating lymphocytes and methods of treatment
GB201618414D0 (en) * 2016-11-01 2016-12-14 Patterson James Regulated cell lines and methods of use thereof
GB201618507D0 (en) * 2016-11-02 2016-12-14 Stichting Voor De Technische Wetenschappen And Wageningen Univ Microbial genome editing
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
JP2020510439A (en) 2017-03-10 2020-04-09 プレジデント アンド フェローズ オブ ハーバード カレッジ Base-editing factor from cytosine to guanine
IL306092A (en) 2017-03-23 2023-11-01 Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
US20200109408A1 (en) * 2017-05-31 2020-04-09 Tropic Biosciences UK Limited Methods of selecting cells comprising genome editing events
WO2019006418A2 (en) 2017-06-30 2019-01-03 Intima Bioscience, Inc. Adeno-associated viral vectors for gene therapy
EP3658573A1 (en) 2017-07-28 2020-06-03 President and Fellows of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
EP3676376A2 (en) 2017-08-30 2020-07-08 President and Fellows of Harvard College High efficiency base editors comprising gam
CN111757937A (en) 2017-10-16 2020-10-09 布罗德研究所股份有限公司 Use of adenosine base editor
BR112020011350A2 (en) 2017-12-08 2020-11-17 Synthetic Genomics, Inc. improvement of lipid productivity of algae through genetic modification of a protein that contains the tpr domain
AU2018395264B2 (en) 2017-12-29 2023-06-22 Synthetic Genomics, Inc. Genetic modulation of photosynthetic organisms for improved growth
WO2019222545A1 (en) * 2018-05-16 2019-11-21 Synthego Corporation Methods and systems for guide rna design and use
US11046979B2 (en) * 2018-07-23 2021-06-29 Synthetic Genomics, Inc. Recombinant algal microorganisms having increased lipid production, and methods of making and using the same
EP3862430A4 (en) * 2018-10-04 2022-06-15 Kaneka Corporation Dna construct to be used in genome editing of plant
JP7460643B2 (en) * 2018-10-16 2024-04-02 ブルーアレル， エルエルシー Methods for targeted insertion of DNA into genes
CN113166774A (en) * 2018-12-19 2021-07-23 合成基因组股份有限公司 Inducible expression of algal genes
WO2020191241A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
US20220177923A1 (en) * 2019-04-05 2022-06-09 Danisco Us Inc Methods for integrating a donor DNA sequence into the genome of bacillus using linear recombinant DNA constructs and compositions thereof
CN110331169A (en) * 2019-07-05 2019-10-15 亢庆铮 It is a kind of efficiently quickly in screening-gene regulatory region functional site method and application
JP7428459B2 (en) * 2019-07-08 2024-02-06 株式会社ユーグレナ Euglena genome modification method and Euglena breeding method
WO2021085580A1 (en) * 2019-10-31 2021-05-06 国立研究開発法人理化学研究所 Polynucleotide and use for same
CA3177481A1 (en) 2020-05-08 2021-11-11 David R. Liu Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
JPWO2022080234A1 (en) * 2020-10-12 2022-04-21
AU2023211606A1 (en) * 2022-01-27 2024-07-11 Asklepios Biopharmaceutical, Inc. Compositions for treating neurological disease
WO2023225358A1 (en) * 2022-05-20 2023-11-23 The Board Of Trustees Of The Leland Stanford Junior University Generation and tracking of cells with precise edits

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304200D0 (en) 1993-03-02 1993-04-21 Sandoz Ltd Improvements in or relating to organic compounds
US5767373A (en) 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US8119859B2 (en) 2008-06-06 2012-02-21 Aurora Algae, Inc. Transformation of algal cells
ES2674583T3 (en) 2011-06-30 2018-07-02 Exxonmobil Research And Engineering Company Regulation of toxin and antitoxin genes for biological confinement
US8709766B2 (en) 2011-10-17 2014-04-29 Colorado School Of Mines Use of endogenous promoters in genetic engineering of Nannochloropsis gaditana
US8809026B2 (en) 2011-12-27 2014-08-19 Commonwealth Scientific And Industrial Research Organisation Processes for producing lipids
US9637739B2 (en) 2012-03-20 2017-05-02 Vilnius University RNA-directed DNA cleavage by the Cas9-crRNA complex
GEP20217251B (en) * 2012-05-25 2021-04-26 Charpentier Emmanuelle De Emanuel Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US10612034B2 (en) 2012-06-01 2020-04-07 Exxonmobil Research And Engineering Company Promoters and terminators for use in eukaryotic cells
US9546372B2 (en) 2012-06-12 2017-01-17 Synthetic Genomics, Inc. Regulatory elements and uses thereof
CA2893692C (en) 2012-12-04 2019-06-25 Exxonmobil Research And Engineering Company Tetraselmis promoters and terminators for use in eukaryotic cells
PT3401388T (en) 2012-12-06 2019-08-29 Synthetic Genomics Inc Algal mutants having a locked-in high light acclimated phenotype
US20140186843A1 (en) 2012-12-12 2014-07-03 Massachusetts Institute Of Technology Methods, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
AU2013359262C1 (en) 2012-12-12 2021-05-13 Massachusetts Institute Of Technology CRISPR-Cas component systems, methods and compositions for sequence manipulation
EP2931899A1 (en) * 2012-12-12 2015-10-21 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
MX2015007550A (en) 2012-12-12 2017-02-02 Broad Inst Inc Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications.
EP4389903A2 (en) * 2013-06-05 2024-06-26 Duke University Rna-guided gene editing and gene regulation
DK3011029T3 (en) * 2013-06-17 2020-03-16 Broad Inst Inc ADMINISTRATION, MODIFICATION AND OPTIMIZATION OF TANDEM GUIDE SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION
WO2015051342A2 (en) 2013-10-04 2015-04-09 Synthetic Genomics, Inc. Compositions and methods for modulating biomass productivity
CN103668472B (en) * 2013-12-31 2014-12-24 北京大学 Method for constructing eukaryon gene knockout library by using CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 system
CN105814190A (en) 2013-12-31 2016-07-27 合成基因组股份有限公司 Biomass productivity regulator
US10968259B2 (en) * 2016-12-30 2021-04-06 Synthetic Genomics, Inc. High productivity algal mutants having reduced photosynthetic antenna

Also Published As

Publication number Publication date
JP2021036866A (en) 2021-03-11
EP3240889A4 (en) 2018-06-20
WO2016109840A3 (en) 2016-10-13
IL252970A0 (en) 2017-08-31
US20210017530A1 (en) 2021-01-21
JP2018500037A (en) 2018-01-11
WO2016109840A9 (en) 2016-11-17
CA2972454A1 (en) 2016-07-07
EP3240889A2 (en) 2017-11-08
JP7046139B2 (en) 2022-04-01
US11339399B2 (en) 2022-05-24
AU2015373893B2 (en) 2021-07-29
AU2015373893A1 (en) 2017-06-15
US20170073695A1 (en) 2017-03-16
SG10201906070XA (en) 2019-08-27
US12043836B2 (en) 2024-07-23
WO2016109840A2 (en) 2016-07-07
IL252970B (en) 2021-07-29

Similar Documents

Publication Publication Date Title
IL252970B (en) Compositions and methods for high efficiency in vivo genome editing
HK1256817A1 (en) Compositions and methods for genome editing
IL277196B (en) Methods and compositions for genome engineering
HK1243333A1 (en) Methods and compositions for modified t cells
HK1257295A1 (en) Compositions and methods for immunooncology
HK1245080A1 (en) Methods and compositions for natural killer cells
HK1253508A1 (en) Compositions and methods for directing proteins to specific loci in the genome
IL259321A (en) Compositions and methods for enhanced gene expression in cone cells
ZA201801578B (en) Methods and compositions for marker-free genome modification
IL251576A0 (en) Methods and compositions for generating or maintaining pluripotent cells
IL247581B (en) Genome editing without nucleases
GB2535253B (en) Compositions and methods
GB201421096D0 (en) Genome editing methods
ZA201703443B (en) Oral rehydration composition and methods thereof
GB201417828D0 (en) New methods and compositions
IL246879A0 (en) Apilimod compositions and methods for using same
ZA201703123B (en) Combination long acting compositions and methods for hepatitis c
GB201402915D0 (en) Compositions and methods
RS56048B1 (en) Improved compositions and methods for fructoborate complexes
PL2990058T3 (en) Improved compositions and methods for fructoborate complexes
GB201403212D0 (en) Compositions and methods